Absence of CXCL10 aggravates herpes stromal keratitis with reduced primary neutrophil influx in mice

Journal of Virology

Volumn 87, Issue 15, 2013, Pages 8502-8510

  Shen, Fang Hsiu ^a   Wang, Shainn Wei ^a   Yeh, Trai Ming ^a   Tung, Yuk Ying ^b   Hsu, Sheng Min ^a   Chen, Shun Hua ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b Institute of Education   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 2; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; CORNEA OPACITY; DISEASE SEVERITY; FEMALE; HERPES SIMPLEX KERATITIS; LYMPHOCYTE MIGRATION; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRAL CLEARANCE; VIRUS LOAD; VIRUS TITRATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINE CXCL10; CHEMOKINES; CORNEA; DISEASE MODELS, ANIMAL; FEMALE; HERPESVIRUS 1, HUMAN; KERATITIS, HERPETIC; MALE; MICE; MICE, INBRED C57BL; NEUTROPHILS; TIME FACTORS;

EID: 84880610803     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01198-13     Document Type: Article

References (52)

1. Biswas PS, Rouse BT. 2005. Early events in HSV keratitis-setting the stage for a blinding disease. Microbes Infect. 7:799-810.
2. Hendricks RL. 1997. An immunologist's view of herpes simplex keratitis: Thygeson lecture 1996, presented at the Ocular Microbiology and Immunology Group meeting, October 26, 1996. Cornea 16:503-506.
3. Babu JS, Thomas J, Kanangat S, Morrison LA, Knipe DM, Rouse BT. 1996. Viral replication is required for induction of ocular immunopathology by herpes simplex virus. J. Virol. 70:101-107.
4. Tumpey TM, Chen SH, Oakes JE, Lausch RN. 1996. Neutrophilmediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J. Virol. 70:898-904.
5. Thomas J, Gangappa S, Kanangat S, Rouse BT. 1997. On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis. J. Immunol. 158:1383-1391.
6. Yan XT, Tumpey TM, Kunkel SL, Oakes JE, Lausch RN. 1998. Role of MIP-2 in neutrophil migration and tissue injury in the herpes simplex virus-1-infected cornea. Invest. Ophthalmol. Vis. Sci. 39:1854-1862.
7. Frank GM, Buela KA, Maker DM, Harvey SA, Hendricks RL. 2012. Early responding dendritic cells direct the local NK response to control herpes simplex virus 1 infection within the cornea. J. Immunol. 188:1350-1359.
8. Conrady CD, Zheng M, Mandal NA, van Rooijen N, Carr DJ. 2013. IFN-alpha-driven CCL2 production recruits inflammatory monocytes to infection site in mice. Mucosal Immunol. 6:45-55.
9. Tumpey TM, Cheng H, Cook DN, Smithies O, Oakes JE, Lausch RN. 1998. Absence of macrophage inflammatory protein-1α prevents the development of blinding herpes stromal keratitis. J. Virol. 72:3705-3710.
10. Zheng M, Deshpande S, Lee S, Ferrara N, Rouse BT. 2001. Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis. J. Virol. 75:9828-9835.
11. Campanella GS, Lee EM, Sun J, Luster AD. 2003. CXCR3 and heparin binding sites of the chemokine IP-10 (CXCL10). J. Biol. Chem. 278:17066-17074.
12. Liu MT, Chen BP, Oertel P, Buchmeier MJ, Armstrong D, Hamilton TA, Lane TE. 2000. The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease. J.Immunol. 165:2327-2330.
13. Boztug K, Carson MJ, Pham-Mitchell N, Asensio VC, DeMartino J, Campbell IL. 2002. Leukocyte infiltration, but not neurodegeneration, in the CNS of transgenic mice with astrocyte production of the CXC chemokine ligand 10. J. Immunol. 169:1505-1515.
14. Soejima K, Rollins BJ. 2001. A functional IFN-gamma-inducible protei-10/CXCL10-specific receptor expressed by epithelial and endothelial cells that is neither CXCR3 nor glycosaminoglycan. J. Immunol. 167:6576-6582.
15. Luster AD, Ravetch JV. 1987. Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J. Exp. Med. 166:1084-1097.
16. Yuan J, Liu Z, Lim T, Zhang H, He J, Walker E, Shier C, Wang Y, Su Y, Sall A, McManus B, Yang D. 2009. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis. Circ. Res. 104:628-638.
17. Chen JP, Lu HL, Lai SL, Campanella GS, Sung JM, Lu MY, Wu-Hsieh BA, Lin YL, Lane TE, Luster AD, Liao F. 2006. Dengue virus induces expression of CXC chemokine ligand 10/IFN-gamma-inducible protein 10, which competitively inhibits viral binding to cell surface heparan sulfate. J. Immunol. 177:3185-3192.
18. Carr DJ, Chodosh J, Ash J, Lane TE. 2003. Effect of anti-CXCL10 monoclonal antibody on herpes simplex virus type 1 keratitis and retinal infection. J. Virol. 77:10037-10046.
19. Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, Luster AD. 2002. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J. Immunol. 168:3195-3204.
20. Gottlieb AB, Luster AD, Posnett DN, Carter DM. 1988. Detection of a gamma interferon-induced protein IP-10 in psoriatic plaques. J. Exp. Med. 168:941-948.
21. Molesworth-Kenyon SJ, Oakes JE, Lausch RN. 2005. A novel role for neutrophils as a source of T cell-recruiting chemokines IP-10 and Mig during the DTH response to HSV-1 antigen. J. Leukoc. Biol. 77:552-559.
22. Hsieh MF, Lai SL, Chen JP, Sung JM, Lin YL, Wu-Hsieh BA, Gerard C, Luster A, Liao F. 2006. Both CXCR3 and CXCL10/IFN-inducible protein 10 are required for resistance to primary infection by dengue virus. J. Immunol. 177:1855-1863.
23. Christensen JE, Simonsen S, Fenger C, Sorensen MR, Moos T, Christensen JP, Finsen B, Thomsen AR. 2009. Fulminant lymphocytic choriomeningitis virus-induced inflammation of the CNS involves a cytokinechemokine-cytokine-chemokine cascade. J. Immunol. 182:1079-1087.
24. Harvey CE, Post JJ, Palladinetti P, Freeman AJ, French RA, Kumar RK, Marinos G, Lloyd AR. 2003. Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation. J. Leukoc. Biol. 74:360-369.
25. Kolb SA, Sporer B, Lahrtz F, Koedel U, Pfister HW, Fontana A. 1999.Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1-infected individuals as interferon-gamma inducible protein 10. J. Neuroimmunol. 93:172-181.
26. Angiolillo AL, Sgadari C, Taub DD, Liao F, Farber JM, Maheshwari S, Kleinman HK, Reaman GH, Tosato G. 1995. Human interferoninducible protein 10 is a potent inhibitor of angiogenesis in vivo. J. Exp. Med. 182:155-162.
27. Bodnar RJ, Yates CC, Wells A. 2006. IP-10 blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation via inhibition of calpain. Circ. Res. 98:617-625.
28. Strieter RM, Kunkel SL, Arenberg DA, Burdick MD, Polverini PJ. 1995. Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis. Biochem. Biophys. Res. Commun. 210:51-57.
29. Aronica SM, Raiber L, Hanzly M, Kisela C. 2009. Antitumor/antiestrogenic effect of the chemokine interferon inducible protein 10 (IP-10) involves suppression of VEGF expression in mammary tissue. J. Interferon Cytokine Res. 29:83-92.
30. Araki-Sasaki K, Tanaka T, Ebisuno Y, Kanda H, Umemoto E, Hayashi K, Miyasaka M. 2006. Dynamic expression of chemokines and the infiltration of inflammatory cells in the HSV-infected cornea and its associated tissues. Ocul. Immunol. Inflamm. 14:257-266.
31. Wuest T, Farber J, Luster A, Carr DJ. 2006. CD4+T cell migration into the cornea is reduced in CXCL9 deficient but not CXCL10 deficient mice following herpes simplex virus type 1 infection. Cell. Immunol. 243:83-89.
32. Metcalf MF, McNeill JI, Kaufman HE. 1976. Experimental disciform edema and necrotizing keratitis in the rabbit. Invest. Ophthalmol. 15:979-985.
33. Hendricks RL, Tumpey TM. 1990. Contribution of virus and immune factors to herpes simplex virus type I-induced corneal pathology. Invest. Ophthalmol. Vis. Sci. 31:1929-1939.
34. Hendricks RL, Janowicz M, Tumpey TM. 1992. Critical role of corneal Langerhans cells in the CD4-but not CD8-mediated immunopathology in herpes simplex virus-1-infected mouse corneas. J. Immunol. 148:2522-2529.
35. Yao HW, Chen SH, Li C, Tung YY, Chen SH. 2012. Suppression of transcription factor early growth response 1 reduces herpes simplex virus 1-induced corneal disease in mice. J. Virol. 86:8559-8567.
36. Luo Y, Dorf ME. 2001. Isolation of mouse neutrophils. Curr. rotoc. Immunol. Chapter 3:Unit 3.20. doi:10.1002/0471142735.im0320s22.
37. Irvine AD, Corden LD, Swensson O, Swensson B, Moore JE, Frazer DG, Smith FJ, Knowlton RG, Christophers E, Rochels R, Uitto J, McLean WH. 1997. Mutations in cornea-specific keratin K3 or K12 genes cause Meesmann's corneal dystrophy. Nat. Genet. 16:184-187.
38. Biswas PS, Banerjee K, Kim B, Smith J, Rouse BT. 2005. A novel low cytometry based assay for quantification of corneal angiogenesis in the mouse model of herpetic stromal keratitis. Exp. Eye Res. 80:73-81.
39. Lokensgard JR, Hu S, Sheng W, vanOijen M, Cox D, Cheeran MC, Peterson PK. 2001. Robust expression of TNF-α, IL-1β, RANTES, and IP-10 by human microglial cells during nonproductive infection with herpes simplex virus. J. Neurovirol. 7:208-219.
40. Taub DD, Lloyd AR, Conlon K, Wang JM, Ortaldo JR, Harada A, Matsushima K, Kelvin DJ, Oppenheim JJ. 1993. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J. Exp. Med. 177:1809-1814.
41. Fenton RR, Molesworth-Kenyon S, Oakes JE, Lausch RN. 2002. Linkage of IL-6 with neutrophil chemoattractant expression in virus-induced ocular inflammation. Invest. Ophthalmol. Vis. Sci. 43:737-743.
42. Fielding CA, McLoughlin RM, McLeod L, Colmont CS, Najdovska M, Grail D, Ernst M, Jones SA, Topley N, Jenkins BJ. 2008. IL-6 regulates neutrophil trafficking during acute inflammation via STAT3. J. Immunol. 181:2189-2195.
43. Molesworth-Kenyon SJ, Popham N, Milam A, Oakes JE, Lausch RN. 2012. Resident corneal cells communicate with neutrophils leading to the production of IP-10 during the primary inflammatory response to HSV-1 infection. Int. J. Inflam. 2012:810359.
44. Gasperini S, Marchi M, Calzetti F, Laudanna C, Vicentini L, Olsen H, Murphy M, Liao F, Farber J, Cassatella MA. 1999. Gene expression and production of the monokine induced by IFN-γ (MIG), IFN-inducible T cell α chemoattractant (I-TAC), and IFN-γ-inducible protein-10 (IP-10) chemokines by human neutrophils. J. Immunol. 162:4928-4937.
45. Spurrell JC, Wiehler S, Zaheer RS, Sanders SP, Proud D. 2005. Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection. Am. J. Physiol. Lung Cell. Mol. Physiol. 289:L85-95.
46. Conrady CD, Jones H, Zheng M, Carr DJ. 2011. A functional type I interferon pathway drives resistance to cornea herpes simplex virus type 1 infection by recruitment of leukocytes. J. Biomed. Res. 25:111-119.
47. Wuest T, Austin BA, Uematsu S, Thapa M, Akira S, Carr DJ. 2006. Intact TRL 9 and type I interferon signaling pathways are required to augment HSV-1 induced corneal CXCL9 and CXCL10. J. Neuroimmunol. 179:46-52.
48. + T-cell recruitment and control of West Nile virus encephalitis. J. Virol. 79:11457-11466.
49. Wuest TR, Carr DJ. 2008. Dysregulation of CXCR3 signaling due to CXCL10 deficiency impairs the antiviral response to herpes simplex virus 1 infection. J. Immunol. 181:7985-7993.
50. Thapa M, Carr DJ. 2008. Herpes simplex virus type 2-induced mortality following genital infection is blocked by anti-tumor necrosis factor alpha antibody in CXCL10-deficient mice. J. Virol. 82:10295-10301.
51. Michalec L, Choudhury BK, Postlethwait E, Wild JS, Alam R, Lett-Brown M, Sur S. 2002. CCL7 and CXCL10 orchestrate oxidative stressinduced neutrophilic lung inflammation. J. Immunol. 168:846-852.
52. Lin YJ, Lai MD, Lei HY, Wing LY. 2006. Neutrophils and macrophages promote angiogenesis in the early stage of endometriosis in a mouse model. Endocrinology 147:1278-1286.